Since depletion of CD25+ regulatory T cells (Treg) from PBMC has been demonstrated to enhance detection of antigen-specific CD4+ T cell responses [34], we additionally stimulated CD25-depleted PBMC from melanoma patients and healthy individuals with library peptide #19. The gene discussed is CD4; the disease is melanoma.